Today: 11 June 2026
Citi stock slips into year-end as traders eye Fed minutes and the next chair call
29 December 2025
2 mins read

Citi stock slips into year-end as traders eye Fed minutes and the next chair call

NEW YORK, December 28, 2025, 19:57 ET — Market closed.

  • Citigroup shares last closed down 0.9% at $120.42 in the Dec. 26 session.
  • Markets turn to Fed minutes due Tuesday and President Donald Trump’s expected pick for the next Fed chair.
  • Citi reports fourth-quarter results on Jan. 14, with investors watching updates on costs and risk-control work.

Citigroup shares ended down 0.9% at $120.42 on Friday, snapping a short run higher in a muted, post-Christmas session.

The move matters heading into the final week of 2025 because bank stocks tend to be highly sensitive to shifts in the interest-rate outlook. Changes in rates can move banks’ net interest margin — the spread between what they earn on loans and what they pay on deposits.

Investors are also bracing for policy headlines that could steer rate expectations in the days ahead, including minutes from the Federal Reserve’s most recent meeting and signals on who will lead the central bank next.

Citi traded between $119.69 and $122.03 in Friday’s session, with volume of about 10.6 million shares, according to market data.

The broader market ended little changed on Friday near record levels, as light holiday volumes kept moves narrow. The S&P 500 slipped 0.03% and the Dow fell 0.04%, while the Nasdaq eased 0.09%, a Reuters market wrap showed.

Bank peers were mixed but generally steady. JPMorgan Chase fell 0.4% and Bank of America slipped 0.1% in the latest session, while Morgan Stanley rose 0.1%.

Strategists have pointed to a late-year rotation into cyclical sectors such as financials after earlier turbulence tied to technology shares. Reuters also noted that year-end portfolio moves can amplify price swings when liquidity thins.

“Handicapping how many rate cuts we’re going to get next year is a big thing markets are focused on right now,” Michael Reynolds, vice president of investment strategy at Glenmede, told Reuters. Reuters

The Fed has lowered its benchmark rate by 75 basis points — a basis point is 0.01 percentage point — over its last three meetings of 2025 to 3.50%-3.75%, Reuters reported. Investors are looking for clues on what comes next.

Markets are also watching for President Donald Trump to nominate a Fed chair to replace Jerome Powell, whose term ends in May, Reuters reported. Any hint on the choice could sway rate expectations and, by extension, financial stocks.

For Citi, investors have also tracked progress on the bank’s multi-year effort to strengthen oversight and control systems after regulatory scrutiny. Earlier this month, Reuters reported the Fed had closed formal notices tied to trading risk management weaknesses, according to people familiar with the matter.

Before the next session, investors will focus on whether thin year-end trading exaggerates moves, especially as the market enters the “Santa Claus rally” window — the last five trading days of the year and the first two of January — watched as a seasonal barometer. Reuters+1

Traders will also be watching near-term levels in Citi’s chart: the stock tested below $120 on Friday, and it would need to clear Friday’s $122.03 high to build fresh momentum, based on the latest session range.

The next company milestone is Citi’s fourth-quarter earnings report, expected Jan. 14 before the opening bell, with executives set to speak on the earnings call the same day, the bank’s investor calendar shows.

Stock Market Today

  • Mister Car Wash Delisted from Nasdaq at $7 After Leonard Green Buyout
    June 11, 2026, 10:45 AM EDT. Mister Car Wash (MCW) was delisted from Nasdaq following its $3.1 billion take-private buyout by Leonard Green & Partners at $7.00 per share in cash. Trading ceased on May 18, 2026, with shares no longer active on public markets. The deal ends MCW's public reporting obligations and removes it from the S&P SmallCap 600 index. CEO John Lai highlighted that going private offers more operational flexibility. Prior to the deal, the company reported growth with Q1 revenue up 6% to $277.9 million and net income rising 26.7% to $34.2 million. The transaction consolidates ownership under Leonard Green, while some management retains stakes in the private firm.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Netflix stock edges up into year-end as Fed minutes, Warner deal stay in focus
Previous Story

Netflix stock edges up into year-end as Fed minutes, Warner deal stay in focus

IonQ drops with quantum peers into year-end, as investors weigh next catalysts
Next Story

IonQ drops with quantum peers into year-end, as investors weigh next catalysts

Go toTop